LINDEN ONCOLOGY LIMITEDActive

Company number SC371591Private limited companyIncorporated 2010

Key figures

£2,862,662+0.1%
Net assets 2024/25
+14.6%
Average annual growth 2020/21–2024/25
01 m2 m3 m2020/212021/222022/232023/242024/25

Like most small UK companies, LINDEN ONCOLOGY LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m3 m2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand689,812883,403476,853458,37692,681
Total assets—————
Total liabilities—————
Net assets / total equity1,658,3201,666,5602,260,1662,860,5072,862,662
Average number of employees11111

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

The principal activity of the Company during the financial year was that of medical and healthcare services.

As described in the company's latest filed accounts.

Summary: LINDEN ONCOLOGY LIMITED

Company

LINDEN ONCOLOGY LIMITED is a private limited company registered with Companies House under company number SC371591. It was incorporated on 21 Jan 2010. Its status is active. The registered office is in Edinburgh (EH3). Its nature of business (SIC 2007) is other business support service activities n.e.c. (82990).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Sep 2025); the company files small company accounts (filleted). Net assets were £2,862,662, up 0.1% on the previous year. Cash at bank and in hand was £92,681. The company had an average of 1 employee. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Jun 2027. The next confirmation statement is due by 4 Feb 2027.